Of note, CD45 presented a negative coefficient in the model, while it was positive for GAPDH and VIL1, thus the former normalizing the later biomarkers for a better performance of GAPDH and VIL1 in the detection of CTC in metastatic CRC patients. The gene discussed is GAPDH; the disease is colorectal carcinoma.